BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Phenobarbital

A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.

297+ PubMed studies analyzed · 9 RCTs · Evidence Score: 40.3

Research Domains

Phenobarbital has been studied across 13 research domains including 🫁 Liver & Detox, 😴 Sleep, 🧠 Focus & Attention, 🔥 Metabolic, 🔬 Oncology. The primary research focus is 🫁 Liver & Detox with 12% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Phenobarbital, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Etidocaine
3 shared targets
Phenytoin
7 shared targets
Leuprolide
5 shared targets
Lamotrigine
5 shared targets
Aztreonam
4 shared targets
Dexamethasone
5 shared targets
Prednisone
6 shared targets
Pinacidil
4 shared targets
Midodrine
4 shared targets
Bupivacaine
3 shared targets
Loading evidence profile...

This evidence profile for Phenobarbital is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.